SAFGANDO Trademark

Trademark Overview

On Monday, January 29, 2024, a trademark application was filed for SAFGANDO with the United States Patent and Trademark Office. The USPTO has given the SAFGANDO trademark a serial number of 98381206. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, August 23, 2024. This trademark is owned by Renibus Therapeutics, Inc.. The SAFGANDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement
safgando

General Information

Serial Number98381206
Word MarkSAFGANDO
Filing DateMonday, January 29, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateFriday, August 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 29, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRenibus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouthlake, TX 76092

Trademark Events

Event DateEvent Description
Monday, January 29, 2024NEW APPLICATION ENTERED
Tuesday, May 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 23, 2024ASSIGNED TO EXAMINER

Related Keywords

safgando pharmaceutical preparations organ lowering risks protecting against associated damage surgery